Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALGeneric

VERDESO

DESONIDE

Standard Dose
0.05%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview VERDESO is listed in Drugs@FDA under application 021978 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient DESONIDE Form and strength AEROSOL, FOAM;TOPICAL - 0.05% Sponsor ALMIRALL Submission history Latest submission status date: 2020-03-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview VERDESO is listed in Drugs@FDA under application 021978 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DESONIDE Form and strength AEROSOL, FOAM;TOPICAL - 0.05% Sponsor ALMIRALL Submission history Latest submission status date: 2020-03-30 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.